Archive for category Medicographia N°102

Download this issue

Bone quality in the treatment of osteoporosis: new approaches, new techniques, and new answers

Editorial

• How innovations are changing our management of osteoporosis
  Comment l’innovation transforme la prise en charge de l’ostéoporose
  M. L. Brandi, Italy

Themed articles

• Osteoporosis: a disease of bone formation
  P. J. Marie, France
• Long-term antifracture efficacy and safety of antiosteoporotic treatments: the hidden part of the iceberg
  J. B. Díaz-López and J. B. Cannata-Andía, Spain
• Adherence to antiosteoporotic treatment: a question of tolerability, mode of administration, or merely good patient dialogue?
  E. C. Fung and T. D. Spector, United Kingdom
• FRAX®, a new tool for assessing fracture risk: clinical applications and
  intervention thresholds
  J. A. Kanis, A. Odén, H. Johansson, F. Borgström,
  O. Ström, and E. V. McCloskey, United Kingdom
• Absolute risk reduction to compare efficacy of antiosteoporotic treatments in the absence of head-to-head trials
  B. Cortet, France

Controversal Question

• Is BMD measurement still useful with the advent of the FRAX® fracture
  risk assessment tool?
  M. Chandran, Singapore – F. S. Hough, South Africa – J. K. Lee, Malaysia -
  W. Lems, The Netherlands – R. Nuti, C. Caffarelli, and S. Gonnelli, Italy -
  M. E. Simões, Portugal – G. Skarantavos, Greece – S. Waikakul,
  Thailand – C. Horváth, Hungary

PROTELOS

• Broad antifracture efficacy coupled with unique benefits on bone: Protelos, the logical response to osteoporosis
  P. Halbout, France

Interview

• National implementation of the ESCEO guidance and its consequences
  J.-Y. Reginster, Belgium

Focus

• Osteoporosis in men
  J. D. Ringe, Germany

Update

• Fracture healing and antiosteoporotic treatments
  G. P. Lyritis, Greece

A Touch of France

• The Big Blue: a touch of French underwater medicine
  C. Régnier, France
• France, a pioneer of underwater archaeology
  D. Camus, France